Health Canada permits temporary import of Chinese-authorized chemo injection drug amid critical shortage
Reported byCBC Health ↗·Sourced by Goodlede
Health Canada has for the first time permitted the exceptional importation and sale of a Chinese-authorized chemotherapy drug (Ifosfamide) to address a critical shortage affecting cancer patients with soft tissue sarcoma, pancreatic, and cervical cancer; the Chinese product has identical active ingredient, strength, dosage form, and reconstitution instructions as the Canadian-authorized version.
The shortage is expected to continue into the first quarter of 2027; this is a temporary mitigation measure rather than a permanent solution.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at CBC Health
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Environment
The young Swedes being paid to make a difference
The Guardian · Verified
Environment
The Majestic 'Gloucester Tree' Reopens to Climbers in Australia After 3 Years of Repair
Good News Network · Verified
Science
Electrek American Solar Challenge 2026: About the race, full schedule, and teams competing
Electrek · Verified